2023-11-15 11:00:04
AstraZeneca Emphasizes Importance of Protecting Premature Babies from RSV on World Prematurity Day
Vienna (OTS) – As the world prepares to observe World Prematurity Day on November 17th, AstraZeneca Austria is highlighting the need for special protection for premature babies and young children from the respiratory syncytial virus (RSV). Premature babies, in particular, are at higher risk for serious RSV infections, making it crucial to take preventive measures to ensure their health and safety.
Dr. Botond Ponner, Medical Director at AstraZeneca Austria, emphasized the importance of working together to protect premature babies, stating, “Premature babies in particular, as a particularly vulnerable group, deserve our special attention and protection. World Prematurity Day reminds us how important it is to work together to maintain the health of our very little ones and to take preventive measures.”
RSV infections pose a significant threat to infants and young children, with almost 100% of all children experiencing at least one RSV infection in the first two years of life. Premature babies are especially vulnerable to serious respiratory infections, such as bronchiolitis, caused by RSV, which can be life-threatening due to their underdeveloped immune systems and lungs.
While RSV infections cannot be treated, AstraZeneca is providing comprehensive information on RSV and preventive measures to help parents and interested parties best protect premature babies and young children. The company’s website offers detailed information about the causes, symptoms, and risk factors of RSV, as well as the latest developments and practical tips for everyday life.
AstraZeneca is a global, research-driven biopharmaceutical company dedicated to developing, producing, and selling innovative medicines in various therapeutic areas, including respiratory diseases. AstraZeneca Austria is committed to advancing the development of therapies and contributing to the cure or alleviation of diseases, including those affecting premature babies and young children.
For more information, visit www.astrazeneca.at or follow AstraZeneca Austria on LinkedIn @AstraZeneca under #astrazenecaaustria and on Facebook/Instagram @astrazenecaaustria.
Media contact:
Simone Farina, Bakk. comm.
External Communication Lead
AstraZeneca Austria GmbH
[email protected]
+43 664 88145 915
AT-10220, November 2023]
#World #Prematurity #Day #AstraZeneca #raises #awareness #RSV #risks